Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

West Pharmaceutical Services Inc. buy Stephens

Start price
€303.70
27.10.23 / 50%
Target price
€368.24
27.10.24
Performance (%)
-5.00%
End price
€288.50
28.10.24
Summary
This prediction ended on 28.10.24 with a price of €288.50. With a performance of -5.00%, the BUY prediction by Stephens finished with a loss. A total of €0.74 was paid as dividends for this prediction. Stephens has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
West Pharmaceutical Services Inc. -5.112% -5.112% -27.958%
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

Comments by Stephens for this prediction

In the thread West Pharmaceutical Services Inc. diskutieren
Prediction Buy
Perf. (%) -5.00%
Target price 368.238
Change
Ends at 27.10.24

West Pharmaceutical Services, Inc. (NYSE: WST) had its price target lowered by analysts at Stephens from $420.00 to $390.00. They now have an "overweight" rating on the stock.
Ratings data for WST provided by MarketBeat

In the thread Trading West Pharmaceutical Services Inc.
Prediction Buy
Perf. (%) -5.00%
Target price 368.238
Change
Ends at 27.10.24

Die von Stephens gewählte maximale Laufzeit wurde überschritten